Study to Evaluate the Efficacy, Safety, Pharmacokinetics and Pharmacodynamic Effects of PQR309 in Glioblastoma Patients

NCT02850744 · clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
10
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

PIQUR Therapeutics AG

Collaborators